Have a feature idea you'd love to see implemented?
Let us know!
INVA Innoviva Inc
Price (delayed)
$19.75
Market cap
$1.24B
P/E Ratio
8.78
Dividend/share
N/A
EPS
$2.25
Enterprise value
$1.47B
Innoviva, Inc. is a healthcare focused asset management company. The Company intends to participate in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva operates in the United States.
Highlights
Innoviva's quick ratio has soared by 71% YoY and by 30% from the previous quarter
The revenue has grown by 14% YoY and by 6% from the previous quarter
The equity has increased by 20% year-on-year but it has declined by 5% since the previous quarter
The stock's price to earnings (P/E) is 43% more than its 5-year quarterly average of 6.2 and 2.8% more than its last 4 quarters average of 8.6
INVA's net income is down by 38% year-on-year and by 20% since the previous quarter
Key stats
What are the main financial stats of INVA
Market
Valuations
Earnings
Shares outstanding
62.56M
Market cap
$1.24B
Enterprise value
$1.47B
Price to book (P/B)
1.85
Price to sales (P/S)
3.74
EV/EBIT
8.38
EV/EBITDA
6.82
EV/Sales
4.44
Revenue
$330.5M
EBIT
$175M
EBITDA
$214.85M
Free cash flow
$157.68M
Per share
Balance sheet
Liquidity
EPS
$2.25
Free cash flow per share
$2.52
Book value per share
$10.66
Revenue per share
$5.29
TBVPS
$15.83
Total assets
$1.22B
Total liabilities
$559.4M
Debt
$447.28M
Equity
$665.52M
Working capital
$330.07M
Debt to equity
0.67
Current ratio
12.7
Quick ratio
11.03
Net debt/EBITDA
1.07
Margins
Efficiency
Dividend
EBITDA margin
65%
Gross margin
87.1%
Net margin
44%
Operating margin
39.9%
Return on assets
11.8%
Return on equity
21.8%
Return on invested capital
14.5%
Return on capital employed
14.6%
Return on sales
53%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INVA stock price
How has the Innoviva stock price performed over time
Intraday
-0.7%
1 week
-0.35%
1 month
2.28%
1 year
59.02%
YTD
23.13%
QTD
2.28%
Financial performance
How have Innoviva's revenue and profit performed over time
Revenue
$330.5M
Gross profit
$287.74M
Operating income
$132.02M
Net income
$145.42M
Gross margin
87.1%
Net margin
44%
The operating margin has plunged by 68% YoY but it has increased by 18% from the previous quarter
INVA's operating income has shrunk by 64% YoY but it is up by 26% QoQ
The net margin has contracted by 45% YoY and by 24% from the previous quarter
INVA's net income is down by 38% year-on-year and by 20% since the previous quarter
Growth
What is Innoviva's growth rate over time
Valuation
What is Innoviva stock price valuation
P/E
8.78
P/B
1.85
P/S
3.74
EV/EBIT
8.38
EV/EBITDA
6.82
EV/Sales
4.44
The stock's price to earnings (P/E) is 43% more than its 5-year quarterly average of 6.2 and 2.8% more than its last 4 quarters average of 8.6
The company's EPS fell by 33% YoY and by 20% QoQ
The P/B is 34% above the last 4 quarters average of 1.4 but 22% below the 5-year quarterly average of 2.4
The equity has increased by 20% year-on-year but it has declined by 5% since the previous quarter
The P/S is 21% higher than the last 4 quarters average of 3.1 and 14% higher than the 5-year quarterly average of 3.3
The revenue has grown by 14% YoY and by 6% from the previous quarter
Efficiency
How efficient is Innoviva business performance
The company's return on sales has shrunk by 52% YoY and by 25% QoQ
The return on invested capital has dropped by 51% year-on-year and by 22% since the previous quarter
INVA's return on equity is down by 46% year-on-year and by 23% since the previous quarter
INVA's ROA is down by 39% YoY and by 22% from the previous quarter
Dividends
What is INVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INVA.
Financial health
How did Innoviva financials performed over time
The total assets is 119% greater than the total liabilities
Innoviva's quick ratio has soared by 71% YoY and by 30% from the previous quarter
The company's current ratio has surged by 55% YoY and by 22% QoQ
The debt is 33% less than the equity
The equity has increased by 20% year-on-year but it has declined by 5% since the previous quarter
The debt to equity has declined by 16% year-on-year but it has grown by 6% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.